Given that CD4+ T cell responses are essential for effective TB immunity (100–107), optimising TB vaccines to elicit robust CD4+ CD1-restricted memory T cell responses may be critical for achieving durable protection. The gene discussed is CD1B; the disease is tuberculosis.